Stay updated on COR388 for AD: Phase 2/3 Clinical Trial

Sign up to get notified when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the COR388 for AD: Phase 2/3 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; Back to Top link removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:58:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:04:57.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as new topics related to drug safety and Alzheimer's care. Notably, previous entries have been removed, indicating a shift in focus or content structure.
    Difference
    3%
    Check dated 2025-08-31T12:17:55.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:38:20.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:32:26.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-01T18:56:51.000Z thumbnail image

Stay in the know with updates to COR388 for AD: Phase 2/3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.